基于CiteSpace的2003-2024年升降散研究文献可视化分析  

CiteSpace-based Visualization Analysis on Literature of Shengjiangsan (升降散) from 2003 to 2024

作　　者：邬倩颖 刘婧 吴恩行 苏冠旬 刘晓玉 杨瑞耕 王世东[1] 尚冬梅 WU Qianying;LIU Jing;WU Enhang;SU Guanxun;LIU Xiaoyu;YANG Ruigeng;WANG Shidong;SHANG Dongmei(Dongzhimen Hospital,Beijing University of Chinese Medicine,Beijing 100700,China)

机构地区：[1]北京中医药大学东直门医院,北京100700

出　　处：《中医药导报》2025年第2期124-130,共7页Guiding Journal of Traditional Chinese Medicine and Pharmacy

基　　金：国家重点研发计划项目(2018YFC1704402)。

摘　　要：目的:梳理升降散研究热点及变化趋势,为后续研究提供思路和参考。方法:检索中国知网(CNKI)、万方数据库、中文科技期刊数据库(VIP)、中国生物医学文献数据库(CBM)2003年1月1日至2024年6月30日发表的升降散相关文献。筛选文献后对机构、关键词进行规范化处理,绘制发文量折线图,运用CiteSpace 6.1.R2软件对作者、机构、关键词进行可视化分析。结果:纳入821篇文献。文献发文量呈波动式上升趋势,文献涉及608位作者、428家研究机构。上海中医药大学的钱义明团队发文量较多。关键词分析显示,研究领域涉及临床应用与理论经验,临床常见疾病涉及传(感)染性疾病(脓毒症、新型冠状病毒感染)、呼吸系统疾病(扁桃体炎、支气管哮喘)、内分泌系统疾病(糖尿病、亚急性甲状腺炎),理论经验以火郁发之、气机升降为主。结论:升降散在临床上应用于治疗外感发热及内伤杂病,内科疾病集中于传(感)染性疾病、呼吸系统疾病、内分泌系统疾病等,儿科疾病与皮肤科疾病也有所涉及。脓毒症、心肌损伤、临证经验是近年持续的研究热点。网络药理学、分子对接等方面可能成为升降散研究新热点。Objective:To sort out the research hotspots and trends of Shengjiangsan,then to provide references for the subsequent theoretical innovation and clinical application research.Methods:Literature related to Shengjiangsan published from 1 January 2003 to 30 June 2024 was searched in CNKI,Wanfang Data,VIP,and CBM.Preliminary screening of the literature and normalisation of institutional units and keywords were carried out.The line graph of the volume of publications was plotted.Authors,source journals,institutions,and keywords were visualized by using CiteSpace 6.1.R2.Results:A total of 821 articles were finally included.The number of publications showed a fluctuating upward trend,with 608 authors and 428 research institutions involved in the literature.The author team with more publications was QIAN Yiming's team from the Shanghai University of Traditional Chinese Medicine.Keyword analysis shows that the research field was mainly consisted of clinical application and theoretical experience.The common clinical diseases involve infectious diseases(sepsis,noval coronavirus pneumonia),respiratory diseases(tonsillitis,asthma),endocrine system diseases(diabetesmellitus,subacute thyroiditis).The theoretical experience is based on dispersing fire and regulating the ascending and descending activities of qi.Conclusion:Shengjiangsan is clinically applied to exogenous fever,internal injuries and miscellaneous diseases,involving paediatrics and dermatology diseases.Internal diseases focus on infectious system,respiratory system,endocrine system,etc.,of which sepsis,myocardial injury,clinical experience are persistent hotspots in recent years.Network pharmacology,molecular docking may become emerging hotspots for research on Shengjiangsan.

关 键 词：升降散 研究热点 CITESPACE 可视化分析 文献计量学 

分 类 号：R289.5[医药卫生—方剂学]